Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Diversifying Away From General Motors: American Axle & Manufact. Holdings, Inc. (AXL)

Page 1 of 2

American Axle & Manufact. Holdings, Inc. (NYSE:AXL) is a Tier I supplier to the automotive industry. American Axle manufactures, engineers, designs, and validates driveline and drivetrain systems and related components and chassis modules for light trucks, sport utility vehicles (SUVs), passenger cars, crossover vehicles and commercial vehicles. In addition to locations in the United States (Michigan, Ohio, Pennsylvania and Indiana), it also has offices or facilities in Brazil, China, Germany, India, Japan, Luxembourg, Mexico, Poland, Scotland, South Korea, Sweden and Thailand.

American Axle & Manufact. Holdings, Inc. (NYSE:AXL)Business Quality

American Axle has made significant efforts to diversify its business through the growth of new and existing customer relationships and the expansion of its product portfolio. It is focused generating profitable growth with new and existing global OEM customers, as well as commercial vehicle, off- road and emerging market OEMs. Its new and expanded business launches in 2013 through 2015 include business with Honda, Jaguar Land Rover, Nissan, Tata Motors, The Volvo Group, Mercedes-Benz, and others. As of December 2012, approximately 90% of the current quoting opportunities amounting to $500 million are for customers other than GM and non‐GM sales are expected to exceed half of American Axle’s total sales by 2015 from its current 30-40%. American Axle also accelerated the development and launch of products for passenger cars and crossover vehicles and the global light truck and commercial vehicle markets. Approximately 60% of its new and incremental business backlog launching from 2013 to 2015 relates to All-Wheel Drive and Rear Wheel Drive applications for passenger cars, crossover vehicles and driveline applications for the commercial vehicle market.

American Axle’s product durability and reliability are driven by its commitment to high quality standards. It has an outstanding daily track record for delivering quality products, having averaged less than 10 discrepant parts per million from 2004 to 2012. Customer incidents per thousand vehicles have improved an average of 15% annually since 2006 from 14 in 2006 to 4 in 2012, resulting in improved warranty performance for customers.

American Axle’s focus on cost management has led to sustainable structural reductions in its fixed cost structure. It shut down the Detroit Manufacturing Complex and the Cheektowaga Manufacturing Facility in 2012 to achieve market cost competitive labor structures and also successfully negotiated several collective bargaining agreements that cover its hourly associates into 2017. It also continued to execute lean management initiatives to improve quality, eliminate waste, reduce lead time and total costs globally.

Valuation and Financial Analysis

American Axle currently trades at a trailing twelve months P/E (excluding extraordinary items) of 11.7 and a trailing twelve months EV/EBITDA of 7.1. Amercian Axle experienced losses in 2006, 2008 and 2009 but has since recorded three consecutive years of profitability from 2010 to 2012. American Axle is highly geared with a net debt-to-EBITDA of 3.6 times. Its refinancing actions taken in 2012 mean that American Axle will not have any major debt refinancing till 2016. According to its presentation at the Deutsche Bank Global Automotive Conference in January 2013, American Axle is targeting net sales and EBITDA to exceed $4 billion and $500 million, respectively, by 2015, based on assumptions of a seasonally adjusted annual rate of 15 million units and the expected launch timing for the programs in its $1.25 billion new business backlog.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!